These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24685065)

  • 1. A systematic review of the management and outcome of toxic epidermal necrolysis treated in burns centres.
    Mahar PD; Wasiak J; Hii B; Cleland H; Watters DA; Gin D; Spinks AB
    Burns; 2014 Nov; 40(7):1245-54. PubMed ID: 24685065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving mortality outcomes of Stevens Johnson syndrome/toxic epidermal necrolysis: A regional burns centre experience.
    Nizamoglu M; Ward JA; Frew Q; Gerrish H; Martin N; Shaw A; Barnes D; Shelly O; Philp B; El-Muttardi N; Dziewulski P
    Burns; 2018 May; 44(3):603-611. PubMed ID: 29029855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing mortality outcomes of major burns and toxic epidermal necrolysis in a tertiary burns centre.
    Mahar PD; Wasiak J; Paul E; Watters DA; Kirby J; Gin D; Marsh P; Cleland H
    Burns; 2014 Dec; 40(8):1743-7. PubMed ID: 24814156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality and use of the auxiliary score in extensive toxic epidermal necrolysis patients admitted to an adult burns referral centre.
    Mahar PD; Wasiak J; Cleland H; Watters D; Paul E; Marsh P; Gin D
    Dermatology; 2013; 227(2):180-5. PubMed ID: 24080507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steven Johnson Syndrome and Toxic Epidermal Necrolysis in a burn unit: A 15-year experience.
    McCullough M; Burg M; Lin E; Peng D; Garner W
    Burns; 2017 Feb; 43(1):200-205. PubMed ID: 27554629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 27 years of a single burn centre experience with Stevens-Johnson syndrome and toxic epidermal necrolysis: analysis of mortality risk for causative agents.
    Weinand C; Xu W; Perbix W; Lefering R; Maegele M; Rathert M; Spilker G
    Burns; 2013 Nov; 39(7):1449-55. PubMed ID: 23702222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hospital management and clinical factors associated with ophthalmic involvement in toxic epidermal necrolysis.
    Hii BW; Mahar PD; Wasiak J; Hall AJ; Paul E; Marsh P; Buck DA; Cleland H
    Burns; 2014 Aug; 40(5):903-8. PubMed ID: 24286611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of patients with toxic epidermal necrolysis syndrome revisited.
    Ducic I; Shalom A; Rising W; Nagamoto K; Munster AM
    Plast Reconstr Surg; 2002 Sep; 110(3):768-73. PubMed ID: 12172137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of Biobrane
    Rogers AD; Blackport E; Cartotto R
    Burns; 2017 Nov; 43(7):1464-1472. PubMed ID: 28526303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and costs of patients with toxic epidermal necrolysis: a 27-year retrospective study.
    Oen IM; van der Vlies CH; Roeleveld YW; Dokter J; Hop MJ; van Baar ME
    J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2444-50. PubMed ID: 26416341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nine years of a single referral center management of Stevens-Johnson syndrome and toxic epidermal necrolysis (Lyell's syndrome).
    Monteiro D; Egipto P; Barbosa J; Horta R; Amarante J; Silva P; Silva A
    Cutan Ocul Toxicol; 2017 Jun; 36(2):163-168. PubMed ID: 27487073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxic epidermal necrolysis (TEN) in elderly patients.
    Honari S; Gibran NS; Heimbach DM; Gibbons J; Pharmd ; Cain V; Engrav LH
    J Burn Care Rehabil; 2001; 22(2):132-5. PubMed ID: 11302601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxic epidermal necrolysis in a burns centre: a 6-year review.
    Khoo AK; Foo CL
    Burns; 1996 Jun; 22(4):275-8. PubMed ID: 8781718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burn Center Care of Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Cartotto R
    Clin Plast Surg; 2017 Jul; 44(3):583-595. PubMed ID: 28576247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of porcine xenografts in patients with toxic epidermal necrolysis.
    Young JB; Gondek SP; Troche M; Summitt JB; Rae L; Thayer WP; Kahn SA
    Burns; 2016 Dec; 42(8):1728-1733. PubMed ID: 27350163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examining triage patterns of inhalation injury and toxic epidermal necrolysis-Stevens Johnson syndrome.
    Davis JS; Pandya RK; Pizano LR; Namias N; Dearwater S; Schulman CI
    J Burn Care Res; 2013; 34(5):492-7. PubMed ID: 23966120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxic epidermal necrolysis: 10 years experience of a burns centre in Hong Kong.
    Ying S; Ho W; Chan HH
    Burns; 2001 Jun; 27(4):372-5. PubMed ID: 11348746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment strategies in toxic epidermal necrolysis syndrome: where are we at?
    Abood GJ; Nickoloff BJ; Gamelli RL
    J Burn Care Res; 2008; 29(1):269-76. PubMed ID: 18182932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxic epidermal necrolysis and concurrent granulomatosis with polyangiitis (Wegener's granulomatosis). Management of a rare case and review of the literature.
    Sofos SS; Ewing J; Hughes LC; James MI
    Scars Burn Heal; 2016; 2():2059513116642129. PubMed ID: 29799572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 10-year experience with toxic epidermal necrolysis.
    Schulz JT; Sheridan RL; Ryan CM; MacKool B; Tompkins RG
    J Burn Care Rehabil; 2000; 21(3):199-204. PubMed ID: 10850900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.